We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.13%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.68B
AUM Growth
-$63.5M
Cap. Flow
-$190M
Cap. Flow %
-5.16%
Top 10 Hldgs %
14.27%
Holding
1,438
New
94
Increased
433
Reduced
653
Closed
139

Sector Composition

Rank Sector Weight
1 Technology 13.28%
2 Healthcare 12.17%
3 Financials 11.04%
4 Consumer Discretionary 8.91%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
301
Sherwin-Williams
SHW
$82.7B
$2.8M 0.08%
18,342
-9,522
-34% -$1.42M
LNT icon
302
Alliant Energy
LNT
$18.3B
$2.79M 0.08%
56,821
+426
+0.8% +$20.3K
CMI icon
303
Cummins
CMI
$87.5B
$2.79M 0.08%
16,265
-2,668
-14% -$437K
USMV icon
304
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
$2.79M 0.08%
45,152
+21,988
+95% +$1.32M
MS icon
305
Morgan Stanley
MS
$331B
$2.78M 0.08%
63,527
+1,470
+2% +$65.6K
EVRG icon
306
Evergy
EVRG
$19.1B
$2.78M 0.08%
46,260
-7,148
-13% -$418K
ET icon
307
Energy Transfer Partners
ET
$70.1B
$2.78M 0.08%
197,431
-13,449
-6% -$199K
FBT icon
308
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$2.77M 0.08%
19,641
+258
+1% +$35.6K
EZM icon
309
WisdomTree US MidCap Fund
EZM
$940M
$2.76M 0.08%
69,012
+29,427
+74% +$1.17M
TMHC
310
DELISTED
Taylor Morrison
TMHC
$2.76M 0.08%
131,693
+16,171
+14% +$322K
MSEX icon
311
Middlesex Water
MSEX
$1.07B
$2.75M 0.07%
46,493
-906
-2% -$52.6K
EL icon
312
Estee Lauder
EL
$30.4B
$2.75M 0.07%
14,997
-2,387
-14% -$408K
KRE icon
313
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
$2.73M 0.07%
51,057
+29,459
+136% +$1.57M
DFS
314
DELISTED
Discover Financial Services
DFS
$2.71M 0.07%
34,909
-5,769
-14% -$447K
SDY icon
315
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$2.7M 0.07%
26,775
+711
+3% +$71.1K
AXTA icon
316
Axalta
AXTA
$7.66B
$2.69M 0.07%
90,285
+2,550
+3% +$67.6K
FXO icon
317
First Trust Financials AlphaDEX Fund
FXO
$1.13B
$2.65M 0.07%
83,821
-7,360
-8% -$230K
MDLZ icon
318
Mondelez International
MDLZ
$79.5B
$2.65M 0.07%
49,220
-4,101
-8% -$213K
XLU icon
319
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
$2.64M 0.07%
88,460
+5,986
+7% +$176K
PRFZ icon
320
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.77B
$2.62M 0.07%
102,530
+43,710
+74% +$1.12M
TYG
321
Tortoise Energy Infrastructure Corp
TYG
$1.09B
$2.59M 0.07%
28,740
-1,307
-4% -$120K
NLY icon
322
Annaly Capital Management
NLY
$17.1B
$2.58M 0.07%
70,694
-3,176
-4% -$121K
GM icon
323
General Motors
GM
$80.4B
$2.58M 0.07%
66,935
-17,235
-20% -$646K
GDV icon
324
Gabelli Dividend & Income Trust
GDV
$2.6B
$2.57M 0.07%
118,680
-14,859
-11% -$318K
VOD icon
325
Vodafone
VOD
$36.3B
$2.56M 0.07%
156,957
-12,438
-7% -$214K

Similar funds

Oppenheimer & Co's Q2 2019 Portfolio in Review

As of Q2 2019, Oppenheimer & Co held 1,438 positions worth $3.68B, down 1.7% from $3.74B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $190M in Q2 2019, closing 139 positions and reducing 653 holdings. Its most notable exit was Amber Road Inc, an estimated $2.06M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in Dow Inc worth $8.02M.

  • Oppenheimer & Co's largest Q2 2019 buy was Dow Inc: 162,710 shares worth $8.02M.
  • Oppenheimer & Co added most to Occidental Petroleum in Q2 2019, an estimated $4.3M increase.
  • Oppenheimer & Co's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $17.5M.
  • Oppenheimer & Co fully exited Amber Road Inc in Q2 2019, selling an estimated $2.06M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2019.
  • Oppenheimer & Co opened 94 new positions and closed 139 in Q2 2019.
  • Oppenheimer & Co's portfolio value fell 1.7% quarter-over-quarter to $3.68B.

Based on Oppenheimer & Co's 13F filing for Q2 2019, filed 9 Aug 2019.